Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
105.285 USD
-0.58%
Updated:
Apr 18, 2024
Abbott Laboratories
Accounts Receivables
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Accounts Receivables Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accounts Receivables
$775.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$3.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
See Also
What is Abbott Laboratories's Accounts Receivables?
Accounts Receivables
6.6B
USD
6.6B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Accounts Receivables amounts to 6.6B USD.
What is Abbott Laboratories's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
5%
5%
Over the last year, the Accounts Receivables growth was 6%. The average annual Accounts Receivables growth rates for Abbott Laboratories have been 1% over the past three years , 5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
